  | Bastos, D. C., Paupert, J., Maillard, C., Seguin, F., Carvalho, M. A., Agostini, M., Coletta, R. D., Noël, A., & Graner, E. (2017). Effects of fatty acid synthase inhibitors on lymphatic vessels: An in vitro and in vivo study in a melanoma model. Laboratory Investigation, 97 (2), 194-206. doi:10.1038/labinvest.2016.125  Peer Reviewed verified by ORBi |
  | DE LANDSHEERE, L., Munaut, C., Nusgens, B., Maillard, C., Rubod, C., Nisolle, M., Cosson, M., & Foidart, J.-M. (December 2013). Histology of the vaginal wall in women with pelvic organ prolapse: a literature review. International Urogynecology Journal, 24 (12), 2011-20. doi:10.1007/s00192-013-2111-1 Peer Reviewed verified by ORBi |
 | Erpicum, C., Detry, B., Paupert, J., Maertens, L., Blacher, S., Maillard, C., Thiry, M., Orménèse, S., Struman, I., Behrendt, N., & Noël, A. (28 January 2013). Lymphangiogenesis and extracellular matrix remodeling [Paper presentation]. GIGA-Day, Liège, Belgium. |
 | Detry, B., Blacher, S., Erpicum, C., Paupert, J., Maertens, L., Maillard, C., Munaut, C., Sounni, N. E., LAMBERT, V., Foidart, J.-M., Rakic, J.-M., Cataldo, D., & Noël, A. (2013). Sunitinib inhibits inflammatory corneal lymphangiogenesis. Investigative Ophthalmology and Visual Science, 54 (5), 3082-93. doi:10.1167/iovs.12-10856 Peer Reviewed verified by ORBi |
 | Shiva Shankar, T. V., Sulka, B., Blacher, S., Maillard, C., Noël, A., Pendeville-Samain, H., Lambert, D., Wouters, J., & Willems, L. (22 June 2012). Understanding angiogenesis through novel epigenetic modulators [Paper presentation]. GIGA Cancer Day, Liege, Belgium. |
 | Detry, B.* , Erpicum, C.* , Paupert, J.* , Blacher, S., Maillard, C., Bruyère, F., Pendeville, H., Remacle, T., LAMBERT, V., Balsat, C., Ormenese, S., Lamaye, F., Janssens, E., Moons, L., CATALDO, D., Kridelka, F., Carmeliet, P., Thiry, M., Foidart, J.-M., ... Noël, A. (24 May 2012). Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase. Blood, 119 (21), 5048-56. doi:10.1182/blood-2011-12-400267 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Bruyere, F., Maillard, C., Erpicum, C., & Noël, A. (2012). Modelling Lymphatic and blood capillary patterning. In J. Davies (Ed.), Replacing Animal Models, a practical guide to creating and using culture-based biomimetic alternatives (pp. 45-56). Wiley-Blackwell. doi:10.1002/9781119940685.ch5 Peer reviewed |
Detry, B., Blacher, S., Erpicum, C., Paupert, J., Maillard, C., Sounni, N. E., LAMBERT, V., & Noël, A. (October 2011). Inhibition of Experimental Corneal Neovascularization by Sunitinib Administration [Poster presentation]. 3ème congrés de la Société Française d'Angiogenèse. |
 | Detry, B., Bruyère, F., Erpicum, C., Paupert, J., Lamaye, F., Maillard, C., Lenoir, B., Foidart, J.-M., Thiry, M., & Noël, A. (24 June 2011). Digging deeper into lymphatic vessel formation in vitro and in vivo. BMC Cell Biology, 12, 29. doi:10.1186/1471-2121-12-29 Peer Reviewed verified by ORBi |
Jost, M., Frankenne, F., Maillard, C., Hubert, P., Herman, L., Delvenne, P., Piette, M., Coia, I., Evrard, B., Lecomte, F., Hubert, P., Englert, Y., Bossens, M., van Pachterbeke, C., GOFFIN, F., Doyen, J., Kridelka, F., Snoeck, R., & FOIDART, J.-M. (20 May 2011). From the Clinics to the Bench and back to the Clinics: design of a medical treatment for Cervical Intraepithelial Neoplasia (CIN) [Paper presentation]. GIGA-Cancer Day, Liège, Belgium. |
 | Shiva Shankar, T. V., Sulka, B., Blacher, S., Maillard, C., Noël, A., Pendeville-Samain, H., Lambert, D., Wouters, J., & Willems, L. (31 January 2011). Novel HDAC/DNMT Twin inhibitors interfere with angiogenesis [Poster presentation]. GIGA day. |
Shiva Shankar, T. V., Sulka, B., Blacher, S., Maillard, C., Noël, A., Pendeville, H., Lambert, D., Wouters, J., & Willems, L. (2011). Novel HDAC/DNMT Twin Inhibitors Interfere with Angiogenesis [Poster presentation]. ICC on Metastasis and Angiogenesis. |
 | Masset, A., Maillard, C., Sounni, N. E., Jacobs, N., Bruyère, F., Delvenne, P., Tacke, M., Reinheckel, T., Foidart, J.-M., Coussens, L., & Noël, A. (2011). Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor. International Journal of Cancer, 128 (2), 283-93. doi:10.1002/ijc.25326 Peer Reviewed verified by ORBi |
 | Kinet, V., Castermans, K., Herkenne, S., Maillard, C., Blacher, S., Lion, M., Noël, A., Martial, J., & Struman, I. (2011). The Angiostatic Protein 16K Human Prolactin Significantly Prevents Tumor-Induced Lymphangiogenesis by Affecting Lymphatic Endothelial Cells. Endocrinology. doi:10.1210/en.2011-1081 Peer Reviewed verified by ORBi |
 | El Hour, M., Moncada-Pazos, A., Blacher, S., Masset, A., Cal, S., Berndt, S., Detilleux, J., Host, L., Obaya, A. J., Maillard, C., Foidart, J.-M., Noël, A.* , & Lopez-Otin, C.*. (2010). Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis. Oncogene, 29 (20), 3025-32. doi:10.1038/onc.2010.49 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Shiva Shankar, T. V., Sulka, B., Blacher, S., Maillard, C., Noël, A., Bellahcene, A., Castronovo, V., Lambert, D., Wouters, J., & Willems, L. (2010). Novel HDAC/DNMT twin inhibitors interfere with angiogenesis [Poster presentation]. Keystone Symposia on Molecular and Cellular Biology. |
 | Bruyere, F.* , Melen-Lamalle, L.* , Blacher, S., Detry, B., Masset, A., Lecomte, J., Lambert, V., Maillard, C., Hoyer-Hansen, G., Lund, L. R., Foidart, J.-M., & Noël, A. (2010). Does plasminogen activator inhibitor-1 drive lymphangiogenesis? PLoS ONE, 5 (3), 9653. doi:10.1371/journal.pone.0009653 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Bajou, K., Peng, H., Laug, W. E., Maillard, C., Noël, A., Foidart, J.-M., Martial, J., & Declerck, Y. A. (2008). Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis. Cancer Cell, 14 (4), 324-34. doi:10.1016/j.ccr.2008.08.012 Peer Reviewed verified by ORBi |
 | Maillard, C., Bouquet, C., Petitjean, M., Mestdagt, M., Frau, E., Jost, M., Masset, A., Opolon, P. H., Beerman, F., Abitbol, M., Foidart, J.-M., Perricaudet, M., & Noël, A. (2008). Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors. Carcinogenesis, 29 (11), 2236-2242. doi:10.1093/carcin/bgn204 Peer Reviewed verified by ORBi |
 | Maillard, C. (2007). Etude de l'implication de PAI-1 (inhibiteur des activateurs du plasminogène de type 1) au cours de la progression tumorale [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315081 |
 | Hubert, P., Herman, L., Maillard, C., Caberg, J.-H., Nikkels, A., Pierard, G., Foidart, J.-M., Noël, A., Boniver, J., & Delvenne, P. (2007). Defensis induce the recruitment of dendritic cells in cervical human papillomavirus-associated (pre)neoplastic lesions formed in vitro and transplanted in vivo. FASEB Journal, 21 (11), 2765-75. doi:10.1096/fj.06-7646com Peer Reviewed verified by ORBi |
 | Jost, M., Maillard, C., Lecomte, J., Lambert, V., Tjwa, M., Blaise, P., Alvarez Gonzalez, M.-L., Bajou, K., Blacher, S., Motte, P., Humblet, C., Defresne, M.-P., Thiry, M., Frankenne, F., Gothot, A., Carmeliet, P., Rakic, J.-M., Foidart, J.-M., & Noël, A. (2007). Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I. American Journal of Pathology, 171 (4), 1369-80. doi:10.2353/ajpath.2007.070074 Peer Reviewed verified by ORBi |
 | Jost, M., Maillard, C., Lambert, V., Tjwa, M., Blaise, P., Lecomte, J., Bajou, K., Blacher, S., Motte, P., Humblet, C., Defresne, M.-P., Thiry, M., Frankenne, F., Gothot, A., Carmeliet, P., Rakic, J.-M., Foidart, J.-M., & Noël, A. (2006). Plasminogen activator inhibitor type I (PAI-1) controls bone marrow-dependent and independent vascularization. Acta Clinica Belgica, 61 (2, MAR-APR), 87. Peer Reviewed verified by ORBi |
Jost, M., Maillard, C., Lecomte, J., Lambert, V., Tjwa, M., Blaise, P., Alvarez Gonzalez, M.-L., Bajou, K., Blacher, S., Motte, P., Humblet, C., Defresne, M.-P., Thiry, M., Frankenne, F., Gothot, A., Carmeliet, P., RAKIC, J.-M., Foidart, J.-M., & Noël, A. (2006). Plasminogen activator inhibitor type 1 (PAI-1) controls bone marrow-dependent and independent vascularization [Poster presentation]. Meeting ABEC/BVSK. |
 | Masson, V., de la Ballina, L. R., Munaut, C., Wielockx, B., Jost, M., Maillard, C., Blacher, S., Bajou, K., Itoh, T., Itohara, S., Werb, Z., Libert, C., Foidart, J.-M., & Noël, A. (February 2005). Contribution of Host MMP-2 and MMP-9 to Promote Tumor Vascularization and Invasion of Malignant Keratinocytes. FASEB Journal, 19 (2), 234-6. doi:10.1096/fj.04-2140fje Peer Reviewed verified by ORBi |
 | Maillard, C., Jost, M., Romer, M. U., Brunner, N., Houard, X., Lejeune, A., Munaut, C., Bajou, K., Melen-Lamalle, L., Dano, K., Carmeliet, P., Fusenig, N. E., Foidart, J.-M., & Noël, A. (January 2005). Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner. Neoplasia, 7 (1), 57-66. doi:10.1593/neo.04406 Peer Reviewed verified by ORBi |
 | Bajou, K., Maillard, C., Jost, M., Lijnen, R. H., Gils, A., Declerck, P., Carmeliet, P., Foidart, J.-M., & Noël, A. (09 September 2004). Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth. Oncogene, 23 (41), 6986-6990. doi:10.1038/sj.onc.1207859 Peer Reviewed verified by ORBi |
 | Noël, A., Maillard, C., Rocks, N., Jost, M., Chabottaux, V., Sounni, N. E., Maquoi, E., Cataldo, D., & Foidart, J.-M. (June 2004). Membrane associated proteases and their inhibitors in tumour angiogenesis. Journal of Clinical Pathology, 57 (6), 577-584. doi:10.1136/jcp.2003.014472 Peer Reviewed verified by ORBi |
 | Hubert, P., Evrard, B., Maillard, C., Franzen-Detrooz, E., Delattre, L., Foidart, J.-M., Noël, A., Boniver, J., & Delvenne, P. (2004). Delivery of granulocyte-macrophage colony-stimulating factor in bioadhesive hydrogel stimulates migration of dendritic cells in models human papillomavirus-associated (pre)neoplastic epithelial lesions. Antimicrobial Agents and Chemotherapy, 48 (11), 4342-4348. doi:10.1128/AAC.48.11.4342-4348.2004 Peer Reviewed verified by ORBi |
 | Rakic, J.-M., Maillard, C., Jost, M., Bajou, K., Masson, V., Devy, L., Lambert, V., Foidart, J.-M., & Noël, A. (March 2003). Role of plasminogen activator-plasmin system in tumor angiogenesis. Cellular and Molecular Life Sciences, 60 (3), 463-473. doi:10.1007/s000180300039 Peer Reviewed verified by ORBi |